DK1181290T3 - Polymorfer af et krystallinsk azabicyclo[2,2,2]octan-3-amin-citrat samt deres farmaceutiske præparater - Google Patents

Polymorfer af et krystallinsk azabicyclo[2,2,2]octan-3-amin-citrat samt deres farmaceutiske præparater

Info

Publication number
DK1181290T3
DK1181290T3 DK00925528T DK00925528T DK1181290T3 DK 1181290 T3 DK1181290 T3 DK 1181290T3 DK 00925528 T DK00925528 T DK 00925528T DK 00925528 T DK00925528 T DK 00925528T DK 1181290 T3 DK1181290 T3 DK 1181290T3
Authority
DK
Denmark
Prior art keywords
polymorphs
octane
well
pharmaceutical preparations
amine citrate
Prior art date
Application number
DK00925528T
Other languages
Danish (da)
English (en)
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1181290T3 publication Critical patent/DK1181290T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00925528T 1999-06-01 2000-05-18 Polymorfer af et krystallinsk azabicyclo[2,2,2]octan-3-amin-citrat samt deres farmaceutiske præparater DK1181290T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01
PCT/IB2000/000665 WO2000073304A1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK1181290T3 true DK1181290T3 (da) 2003-09-29

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00925528T DK1181290T3 (da) 1999-06-01 2000-05-18 Polymorfer af et krystallinsk azabicyclo[2,2,2]octan-3-amin-citrat samt deres farmaceutiske præparater

Country Status (49)

Country Link
US (1) US6255320B1 (ru)
EP (1) EP1181290B1 (ru)
JP (1) JP3830816B2 (ru)
KR (1) KR100476606B1 (ru)
CN (1) CN1146565C (ru)
AP (1) AP2001002349A0 (ru)
AR (1) AR033331A1 (ru)
AT (1) ATE244239T1 (ru)
AU (1) AU767334B2 (ru)
BG (1) BG65240B1 (ru)
BR (1) BR0011094A (ru)
CA (1) CA2372238C (ru)
CO (1) CO5170463A1 (ru)
CY (1) CY2007011I2 (ru)
CZ (1) CZ295819B6 (ru)
DE (1) DE60003679T2 (ru)
DK (1) DK1181290T3 (ru)
DZ (1) DZ3050A1 (ru)
EA (1) EA003731B1 (ru)
EC (1) ECSP003508A (ru)
EE (1) EE200100656A (ru)
ES (1) ES2199825T3 (ru)
GT (1) GT200000087A (ru)
HK (1) HK1046284A1 (ru)
HN (1) HN2000000077A (ru)
HR (1) HRP20010904A2 (ru)
HU (1) HUP0201301A3 (ru)
IL (1) IL146406A0 (ru)
MA (1) MA26742A1 (ru)
MX (1) MXPA01012325A (ru)
MY (1) MY133508A (ru)
NO (1) NO20015848L (ru)
NZ (1) NZ515349A (ru)
OA (1) OA11956A (ru)
PA (1) PA8496101A1 (ru)
PE (1) PE20010209A1 (ru)
PL (1) PL196046B1 (ru)
PT (1) PT1181290E (ru)
SI (1) SI1181290T1 (ru)
SK (1) SK285820B6 (ru)
SV (1) SV2001000093A (ru)
TN (1) TNSN00120A1 (ru)
TR (1) TR200103473T2 (ru)
TW (1) TWI285204B (ru)
UA (1) UA66925C2 (ru)
UY (1) UY26176A1 (ru)
WO (1) WO2000073304A1 (ru)
YU (1) YU81101A (ru)
ZA (1) ZA200109775B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007519702A (ja) * 2004-01-30 2007-07-19 ファイザー・プロダクツ・インク ニューロキニン受容体拮抗薬及びシクロデキストリンからなる医薬組成物、ならびに注射部位の耐容性を改善するための方法
LT1713504T (lt) * 2004-01-30 2017-09-11 Zoetis Services Llc Antimikrobinis konservantas, skirtas multi-dozinėms kompozicijoms, panaudojant beta-ciklodekstrinus, skirtas skystoms vaisto formoms
CN1913893A (zh) * 2004-01-30 2007-02-14 辉瑞产品有限公司 改善麻醉恢复的nk－1受体拮抗剂
ATE380811T1 (de) * 2004-02-02 2007-12-15 Pfizer Prod Inc Verfahren zur herstellung von 1-(2s,3s)-2- benzhydril-n-(5-tert.-butyl-2- methoxybenzyl)chinuklidin-3-amin
KR102391332B1 (ko) * 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639A (zh) * 2019-12-16 2021-06-18 四川科瑞德凯华制药有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69208877T2 (de) * 1991-05-31 1996-07-25 Pfizer Chinuclidinderivate
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
AP2001002349A0 (en) 2001-12-31
EA003731B1 (ru) 2003-08-28
CO5170463A1 (es) 2002-06-27
SK17332001A3 (sk) 2002-07-02
EP1181290B1 (en) 2003-07-02
TNSN00120A1 (fr) 2005-11-10
KR100476606B1 (ko) 2005-03-18
NO20015848D0 (no) 2001-11-30
CY2007011I1 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
KR20020010688A (ko) 2002-02-04
OA11956A (en) 2006-04-13
ATE244239T1 (de) 2003-07-15
AR033331A1 (es) 2003-12-17
EP1181290A1 (en) 2002-02-27
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
PL352716A1 (en) 2003-09-08
DZ3050A1 (fr) 2004-03-27
HUP0201301A2 (en) 2002-08-28
IL146406A0 (en) 2002-07-25
MY133508A (en) 2007-11-30
BG65240B1 (bg) 2007-09-28
YU81101A (sh) 2004-07-15
MXPA01012325A (es) 2002-07-22
HUP0201301A3 (en) 2002-10-28
CZ295819B6 (cs) 2005-11-16
ZA200109775B (en) 2002-11-28
CY2007011I2 (el) 2010-07-28
WO2000073304A1 (en) 2000-12-07
TR200103473T2 (tr) 2002-04-22
UA66925C2 (ru) 2004-06-15
UY26176A1 (es) 2000-12-29
JP2003501354A (ja) 2003-01-14
SV2001000093A (es) 2001-11-08
BR0011094A (pt) 2002-03-19
DE60003679D1 (de) 2003-08-07
NZ515349A (en) 2004-03-26
SK285820B6 (sk) 2007-09-06
PA8496101A1 (es) 2002-07-30
ES2199825T3 (es) 2004-03-01
CN1353711A (zh) 2002-06-12
ECSP003508A (es) 2002-02-25
AU4424800A (en) 2000-12-18
GT200000087A (es) 2001-11-22
PT1181290E (pt) 2003-09-30
MA26742A1 (fr) 2004-12-20
TWI285204B (en) 2007-08-11
CA2372238C (en) 2006-12-19
HK1046284A1 (en) 2003-01-03
CA2372238A1 (en) 2000-12-07
PL196046B1 (pl) 2007-11-30
HN2000000077A (es) 2001-02-02
JP3830816B2 (ja) 2006-10-11
EE200100656A (et) 2003-02-17
CN1146565C (zh) 2004-04-21
BG106204A (en) 2002-07-31
AU767334B2 (en) 2003-11-06
PE20010209A1 (es) 2001-03-01
SI1181290T1 (en) 2003-12-31
CZ20014269A3 (cs) 2002-04-17
EA200101108A1 (ru) 2002-04-25
DE60003679T2 (de) 2004-05-27

Similar Documents

Publication Publication Date Title
HUP0204034A3 (en) Stable salts of novel derivatives of 3,3-diphenylpropylamines
DK2050445T3 (da) Farmaceutisk sammensætning af phenofibrat med forøget biotilgængelighed samt fremgangsmåde til dens fremstilling
DE60038481D1 (de) Kristalline form des (r)-2-äää3-methyl-4-(2,2,2-trifluorethoxy)-2-pyridinylümethylüsulfinylü-1h-benzimidazols
AU5108000A (en) Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
MA26816A1 (fr) Derives d'amino-triazolopyridine
NO20021398D0 (no) 2'-substituerte 1,1'-bifenyl-2-karbonamider, fremgangsmåte for fremstilling, deres anvendelse som medikament såvel somfarmasöytiske preparater inneholdende disse
NO20006039L (no) Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin
ITTO20000281A0 (it) Gruppo d'assemblaggio per cursore-linguetta di trazione di una cerniera lampo.
PT1165081E (pt) Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
DK1181290T3 (da) Polymorfer af et krystallinsk azabicyclo[2,2,2]octan-3-amin-citrat samt deres farmaceutiske præparater
ATE339438T1 (de) Substanziell kristalline form von melagatran
DK1216226T3 (da) Fremgangsmåde til fremstilling af phenyleddikesyrederivater
NO20020059D0 (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20014051D0 (no) Fremgangsmate for fremstilling av et noringsmiddel
NO20013995L (no) Fremgangsmåte for fremstilling av L-sorbose
NO20014383L (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
HUP0000982A2 (en) Process for the preparation of 1,1-dioxo-penicillanic acid derivatives
DK1080076T3 (da) Forbedret fremgangsmåde til fremstilling af farmaceutisk værdifulde norbenzomorphanderivater
EE200000369A (et) Isopropüülmetüül[2-(3-n-propoksüfenoksü)etüül]amiini valmistamise protsess
DK1012143T3 (da) Fremgangsmåde til fremstilling af 1-phenylpyrazolin-3-carboxylsyrederivater
FI991294A (fi) Nikkelirikasteen valmistusmenetelmä
HU9904011D0 (en) Novel salts of dipeptid derivatives